December 15, 2025 argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease
October 29, 2025 argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients
Follow us
Get the latest news and info via our social media channels.